Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

414
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
414

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dilemmas in diagnosing Alzheimer's disease: The peril and promise of self-fulfilling prophecies.

Journal of Alzheimer's disease : JAD·2025
See all related articles

Related Experiment Video

Updated: Sep 27, 2025

MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor
05:54

MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor

Published on: December 13, 2017

14.2K

Treatment Patterns in Essential Tremor: A Retrospective Analysis.

Chintan Shah1, George R Jackson1,2, Aliya I Sarwar2

  • 1Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas, US.

Tremor and Other Hyperkinetic Movements (New York, N.Y.)
|April 13, 2022
PubMed
Summary

Essential tremor (ET) treatments vary, with many patients not receiving adequate care. This study surveyed ET management, revealing limitations in conventional therapies and suggesting a need for non-pharmacological approaches.

Keywords:
botulinum toxinclinicaldeep brain stimulationessential tremormedicationtreatment

More Related Videos

Structured Motor Rehabilitation After Selective Nerve Transfers
09:34

Structured Motor Rehabilitation After Selective Nerve Transfers

Published on: August 15, 2019

22.4K
A Standardized Method for Measurement of Elbow Kinesthesia
07:56

A Standardized Method for Measurement of Elbow Kinesthesia

Published on: October 10, 2020

7.2K

Related Experiment Videos

Last Updated: Sep 27, 2025

MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor
05:54

MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor

Published on: December 13, 2017

14.2K
Structured Motor Rehabilitation After Selective Nerve Transfers
09:34

Structured Motor Rehabilitation After Selective Nerve Transfers

Published on: August 15, 2019

22.4K
A Standardized Method for Measurement of Elbow Kinesthesia
07:56

A Standardized Method for Measurement of Elbow Kinesthesia

Published on: October 10, 2020

7.2K

Area of Science:

  • Neurology
  • Clinical Medicine
  • Pharmacology

Background:

  • First-line therapies for essential tremor (ET) show variable patient responses.
  • Current understanding of ET treatment efficacy is based on limited clinical trial data.
  • A survey was conducted to assess tremor management in a large cohort of ET patients.

Purpose of the Study:

  • To evaluate current treatment practices for essential tremor in a large patient population.
  • To identify patterns of pharmacotherapy and non-pharmacological interventions for ET.
  • To assess the effectiveness and tolerability of different ET treatments.

Main Methods:

  • A retrospective chart review was performed on 1468 patients diagnosed with ET.
  • Data on temporal course, treatment, and medication response were extracted from medical records.
  • The study identified patients receiving no treatment, monotherapy, or multiple pharmacotherapies.

Main Results:

  • Of 1074 ET patients, 27.1% received no treatment; 46.6% received monotherapy.
  • Primidone (46.6%) and propranolol (35.8%) were the most prescribed medications.
  • 13.4% of prescriptions were discontinued due to side effects, and 17.5% were ineffective.

Conclusions:

  • Conventional ET treatments have limitations, with significant rates of ineffectiveness and side effects.
  • A substantial proportion of ET patients do not receive any treatment.
  • Improved outcomes in ET populations may require greater recognition of treatment limitations and increased use of non-pharmacological therapies.